CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for March 2011 and Other Metrics

NYSE Liffe U.S. Executes 480,000 Eurodollar and U.S. Treasury Futures Contracts Since March 21 Global Derivatives Averaged 9.2 Million Contracts per Day in March, Up 12% vs. Prior Year U.S Equity Options Volumes Up 23%; European Derivatives Up 3% European Cash Trading Volumes Up 44%, U.S. Cash Down 2%

April 6, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for March 2011¹ . Global derivatives average daily volume ("ADV") of 9.2 million contracts traded per day in March 2011 increased 11.9% versus the prior year. The increase in global derivatives ADV versus prior year levels was driven by a 22.8% increase in U.S. equity options ADV and a 3.2% increase in European Derivatives ADV. Cash equities ADV in March 2011 was mixed, with European cash ADV increasing 44.0% and U.S. cash trading volumes decreasing 2.1% from March 2010 levels.

Highlights

NYSE Euronext global derivatives ADV in March 2011 of 9.2 million contracts increased 11.9% compared to March 2010 and increased 2.5% from February 2011 levels.
NYSE Euronext European derivatives products ADV in March 2011 of 4.8 million contracts increased 3.2% compared to March 2010 and increased 8.0% from February 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 3.9% compared to March 2010, but decreased 0.9% from February 2011. Total European fixed income products ADV in March 2011 of 2.7 million contracts increased 1.6% compared to March 2010, but decreased 5.0% from February 2011. Total equity products ADV of 2.0 million contracts in March 2011 increased 2.9% compared to March 2010 and increased 31.6% from February 2011. Total commodities products ADV of 101,000 contracts in March 2011 increased 95.5% compared to March 2010 and increased 16.6% from February 2011.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.4 million contracts in March 2011 increased 22.8% compared to March 2010 levels, but decreased 3.4% from February 2011. NYSE Euronext's U.S. options exchanges accounted for 26.0% of total U.S. consolidated equity options trading in March 2011, up from 25.3% in March 2010 and up from 25.9% recorded in February 2011.
NYSE Liffe U.S., the U.S. futures exchange of NYSE Euronext, launched Eurodollar and U.S. Treasury futures on March 21 and March 28, respectively, and approximately 480,000 contracts were executed during the first nine trading days in March. A wide range of clients are now trading over the platform and open interest continues to grow.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

The pipeline of new trading clients is strong, with several new clients expected to begin trading in the coming weeks.

NYSE Euronext European cash products ADV of 1.9 million transactions in March 2011 increased 44.0% compared to March 2010 and increased 5.1% from February 2011 levels.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.3 billion shares in March 2011 decreased 2.1% compared to March 2010, but increased 2.7% compared to February 2011. NYSE Euronext's Tape A matched market share in March 2011 was 35.1%, up from 33.6% in March 2010 and up from 34.5% in February 2011.
There were a total of 23 trading days in Europe and the U.S. in both March 2011 and March 2010.
The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the first quarter of 2011 is included below:

	4Q10 Actual	1Q11 Preliminary
1 European Derivatives (ex. Bclear)	\$0.67	\$0.68
U.S. Equity Options2	\$0.17	\$0.16
European Cash3	\$0.71	\$0.65
U.S. Cash4	\$0.033	\$0.036

1 Average net revenue per contract, excluding Bclear.

2 Average net revenue per contract.

³ Average net revenue per transaction.

⁴ Average net revenue per 100 shares handled.

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in March 2011 was 4.8 million futures and options contracts, an increase of 3.2% from March 2010 and an increase of 8.0% from February 2011. The 4.8 million in futures and options contracts ADV in March 2011 consisted of 3.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 18.0%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 3.9% compared to March 2010 and decreased 0.9% from February 2011.
In the first quarter of 2011, European derivatives products ADV of 4.6 million contracts was 4.5% below prior year levels. The 4.6 million in futures and options contracts ADV in the first quarter of 2011 consisted of 3.9 million contracts executed through LIFFE CONNECT trading platform and 0.8 million contracts, or 16.6%, executed through Bclear.
The anticipated average net rate per contract for European derivatives, excluding Bclear, is expected to be approximately \$0.68 per contract in the first quarter of 2011.
Total fixed income products ADV of 2.7 million contracts in March 2011 increased 1.6% from March 2010, but decreased 5.0% from February 2011. In the first quarter of 2011, total fixed income products ADV of 2.7 million contracts was 0.4% below prior year levels.
Total equity products (including Bclear) ADV of 2.0 million contracts in March 2011 increased 2.9% compared to March 2010 and increased 31.6% from February 2011. The 2.0 million contracts in equity products ADV consisted of 1.3 million contracts in

individual equity products ADV and 0.7 million contracts in equity index products ADV. The 1.3 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented an 8.0% increase compared to March 2010 and 0.6 million in options contracts, which represented a 9.7% decrease compared to March 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. In the first quarter of 2011, total equity products ADV of 1.8 million contracts was 11.6% below prior year levels.

• Total commodities products ADV of 101,000 contracts in March 2011 increased 95.5% compared to March 2010 and increased 16.6% compared to February 2011. In the first quarter of 2011, total commodities product ADV of 88,000 contracts was 69.2% above prior year levels.

U.S. Derivatives

NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.4 million contracts in March 2011 increased 22.8% compared to March 2010, but decreased 3.4% compared to February 2011. In the first quarter of 2011, U.S. equity options ADV of 4.4 million contracts was 18.8% above prior year levels.
The anticipated average net rate per contract for U.S. equity options is expected to be approximately \$0.16 per contract in the first quarter of 2011.
Total U.S. consolidated equity options ADV increased 19.3% to 16.8 million contracts in March 2011 compared to March 2010, but decreased 3.9% compared to February 2011. In the first quarter of 2011, U.S. consolidated equity options ADV of 17.3 million contracts was 23.8% above prior year levels.
NYSE Euronext's U.S. options exchanges accounted for 26.0% of the total U.S. consolidated equity options trading in March 2011, up from 25.3% in March 2010 and up from 25.9% in February 2011.
NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in March 2011 was approximately 35,600 contracts, compared to 18,200 contracts in March 2010.
NYSE Liffe U.S. launched Eurodollar and U.S. Treasury futures on March 21 and March 28, respectively, and approximately 480,000 contracts were executed during the first nine trading days in March. A wide range of clients are now trading over the platform and open interest continues to grow. The pipeline of new trading clients is strong, with several new clients expected to begin trading in the coming weeks.
In the first quarter of 2010, U.S. futures and futures options ADV of 21,700 contracts was 4.6% above prior year levels.

Cash Trading

European Cash

NYSE Euronext European cash products ADV of 1.9 million transactions in March 2011 increased 44.0% compared to March 2010 and increased 5.1% compared to February 2011.
In the first quarter of 2011, European cash products ADV of 1.8 million transactions was 31.7% above prior year levels.
The anticipated average net revenue per transaction for European cash is expected to be approximately \$0.65 per transaction in the first quarter of 2011.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in March 2011 decreased 2.1% to 2.3 billion shares compared to March 2010, but increased 2.7% from February 2011.

In the first quarter of 2011, U.S. cash products handled ADV was 2.3 billion shares, down 9.1% from prior year levels.
The anticipated average net revenue per 100 shares handled for U.S. cash is expected to be approximately \$0.036 per 100 shares handled in the first quarter of 2011.
NYSE Euronext's Tape A matched market share in March 2011 was 35.1%, up from 33.6% in March 2010 and up from 34.5% in February 2011.

Exchange Traded Funds

NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 315 million shares in March 2011 increased 15.5% compared to March 2010 and increased 21.7% compared to February 2011.
In the first quarter of 2011, NYSE Euronext U.S. matched exchange-traded funds ADV of 283 million shares was 12.7% below prior year levels.

Other Metrics

The average EUR/USD exchange rate for the first quarter of 2011 of \$1.37 represented an increase of 0.7% from the fourth quarter of 2010 and a decrease of 1.1% compared to the first quarter of 2010.
The average GBP/USD exchange rate for the first quarter of 2011 of \$1.60 represented an increase of 1.3% from the fourth quarter of 2010 and an increase of 2.7% compared to the first quarter of 2010.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release August contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2010 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results August be materially higher or lower than those projected. The inclusion of

such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Mar-11	Mar-10	% Chg	Mar-11	Mar-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	23 23	23 23		23 23	23 23		64 62		64 62
European Derivatives Products of which Bclear	4,771 861	4,622 860	3.2% 0.1%	109,733 106,307 19,806	19,778	3.2% 0.1%	4,633 771	-4.5% -20.7%	296,529 49,335	-3.0% -19.4%
Total Fixed Income Products	2,673	2,630	1.6%	61,468	60,484	1.6%	2,700	-0.4%	172,792	1.2%
Short Term Interest Rate Products	2,546	2,523	0.9%	58,566	58,039	0.9%	2,568	-1.0%	164,371	0.6%
Medium and Long Term Interest Rate Products 1	126	106	18.7%	2,902	2,445	18.7%	132	12.0%	8,421	13.8%
Total Equity Products 2	1,997	1,941	2.9%	45,935	44,632	2.9%	1,845	-11.6%	118,110	-10.2%
Individual Equity Products Futures	1,294 650	1,315 602	-1.6% 8.0%	29,755 14,953	30,242 13,851	-1.6% 8.0%	1,266 575	-13.6% -20.8%	81,011 36,777	-12.3% -19.5%
Options	644	713	-9.7%	14,802	16,391	-9.7%	691	-6.6%	44,234	-5.1%
Equity Index Products	703	626	12.4%	16,180	14,390	12.4%	580	-6.8%	37,100	-5.3%
of which Bclear	861	860	0.1%	19,806	19,778	0.1%	771	-20.7%	49,335	-19.4%
Individual Equity Products Futures	747 649	737 600	1.3% 8.1%	17,188 14,927	16,961 13,810	1.3% 8.1%	690 569	-19.0% -21.4%	44,152 36,437	-17.7% -20.2%
Options	98		137 -28.2%	2,262		3,151 -28.2%	121	-4.8%	7,715	-3.3%
Equity Index Products	114	123	-7.1%	2,618	2,818	-7.1%	81	-32.9%	5,183	-31.8%
Commodity Products	101	52	95.5%	2,329	1,191	95.5%	88	69.2%	5,627	71.9%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts Total Consolidated Options Contracts	4,368 16,791	3,556 14,071	22.8% 19.3%	100,472 386,203 323,642	81,792	22.8% 19.3%	4,408 17,298	18.7% 23.8%	273,323 1,072,501	20.7% 25.8%
NYSE Group Share of Total	26.0%	25.3%		26.0%	25.3%		25.5%	-1.1%	25.5%	-1.1%
NYSE Liffe U.S.
Futures and Futures Options Volume	35.6	18.2	95.9%	818	418	95.9%	21.7	4.6%	1,347.3	6.3%
European Cash Products (trades in thousands)	1,862	1,293	44.0%	42,822	29,737	44.0%	1,803	31.7%	115,377	33.8%
Equities	1,787		1,243 43.7%	41,090		28,586 43.7%	1,732	31.9%	110,841	34.0%
Exchange-Traded Funds	22		14 59.8%	516		323 59.8%	21	28.1%	1,316	30.1%
Structured Products Bonds	47 6		29 61.7% 7 -17.8%	1,089 127		674 61.7% 154 -17.8%	45 5	33.7% -14.6%	2,873 347	35.8% -13.3%
U.S. Cash Products (shares in millions) 5	2,307	2,357	-2.1%	53,055 54,214		-2.1%	2,309	-9.1%	143,176	-7.6%
NYSE Listed (Tape A) Issues 4
Handled Volume 5	1,632	1,725	-5.4%	37,537	39,677	-5.4%	1,668	-8.6%	103,391	-7.1%
Matched Volume 6	1,549	1,599	-3.1%	35,633	36,785	-3.1%	1,577	-6.8%	97,799	-5.2%
Total NYSE Listed Consolidated Volume	4,409	4,756	-7.3%		101,413 109,392	-7.3%	4,568	-6.1%	283,205	-4.6%
Share of Total Consolidated Volume Handled Volume 5
Matched Volume 6	37.0% 35.1%	36.3% 33.6%	0.7% 1.5%	37.0% 35.1%	36.3% 33.6%	0.7% 1.5%	36.5% 34.5%	-1.0% -0.2%	36.5% 34.5%	-1.0% -0.2%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume 5	383	324	18.5%	8,820	7,445	18.5%	347	-9.1%	21,491	-7.6%
Matched Volume 6	344	289	19.0%	7,906	6,642	19.0%	311	-7.9%	19,270	-6.4%
Total NYSE Arca & Amex Listed Consolidated Volume	1,475	1,260	17.1%	33,931	28,974	17.1%	1,351	-8.1%	83,751	-6.6%
Share of Total Consolidated Volume Handled Volume 5	26.0%	25.7%	0.3%	26.0%	25.7%	0.3%	25.7%	-0.2%	25.7%	-0.2%
Matched Volume 6	23.3%	22.9%	0.4%	23.3%	22.9%	0.4%	23.0%	0.1%	23.0%	0.1%
Nasdaq Listed (Tape C) Issues
Handled Volume 5	291	308	-5.6%	6,697	7,092	-5.6%	295	-12.1%	18,295	-10.7%
Matched Volume 6	247	249	-0.6%	5,690	5,725	-0.6%	251	-8.5%	15,572	-7.0%
Total Nasdaq Listed Consolidated Volume	2,020	2,324	-13.1%	46,470	53,456	-13.1%	2,051	-12.3%	127,166	-10.9%
Share of Total Consolidated Volume Handled Volume 5	14.4%	13.3%	1.1%	14.4%	13.3%	1.1%	14.4%	0.0%	14.4%	0.0%
Matched Volume 6	12.2%	10.7%	1.5%	12.2%	10.7%	1.5%	12.2%	0.5%	12.2%	0.5%
Exchange-Traded Funds 5,7
Handled Volume 5	351	304	15.6%	8,077	6,986	15.6%	315	-13.5%	19,557	-12.1%
Matched Volume 6	315	272	15.5%	7,235	6,263	15.5%	283	-12.7%	17,543	-11.3%
Total ETF Consolidated Volume	1,368	1,216	12.5%	31,455	27,972	12.5%	1,245	-13.7%	77,213	-12.3%
Share of Total Consolidated Volume Handled Volume 5	25.7%	25.0%	0.7%	25.7%	25.0%	0.7%	25.3%	0.0%	25.3%	0.0%
Matched Volume 6	23.0%	22.4%	0.6%	23.0%	22.4%	0.6%	22.7%	0.2%	22.7%	0.2%

7 Data included in previously identified categories.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

4 Includes all volume executed in NYSE Group crossing sessions.

NYSE Euronext Monthly Volume Summary

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.

AI Terminal

Euronext N.V.

3839_iss_2011-04-06_028f3807-5951-4b1c-baec-53c5c1aae948.pdf